In vivo immunomodulatory effects by uPAR-retargeted oncolytic Measles virus

被引：0
|
作者：
Khatwani, Natasha K. [1 ]
Jing, Yuqi [1 ]
Chavez, Valery [1 ]
Merchan, Jaime [1 ]
机构：
[1] Univ Miami, Miami, FL USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-1734
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1734
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Mechanisms of measles virus oncolytic immunotherapy
    Pidelaserra-Marti, Gemma
    Engeland, Christine E.
    CYTOKINE & GROWTH FACTOR REVIEWS, 2020, 56 : 28 - 38
  • [32] Measles virus as an oncolytic vector platform
    Blechacz, Boris
    Russell, Stephen J.
    CURRENT GENE THERAPY, 2008, 8 (03) : 162 - 175
  • [33] Specific elimination of CD133+tumor cells with retargeted oncolytic measles viruses
    Abel, Tobias
    Bach, Patricia
    Hoffmann, Christopher
    Gal, Zoltan
    Braun, Gundula
    Voelker, Iris M.
    Ball, Claudia R.
    Johnston, Ian C. D.
    Lauer, Ulrich M.
    Herold-Mende, Christel
    Muehlebach, Michael D.
    Glimm, Hanno
    Buchholz, Christian J.
    HUMAN GENE THERAPY, 2012, 23 (10) : A90 - A91
  • [34] Fully retargeted oncolytic measles virus specific for the WUE-Ag results in specific lysis of multiple myeloma cells.
    Hummel, HD
    Nakamura, T
    Kuntz, G
    Einsele, H
    Russell, SJ
    Topp, MS
    BLOOD, 2005, 106 (11) : 854A - 854A
  • [35] Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity
    Allen, Cory
    Paraskevakou, Georgia
    Iankov, Ianko
    Giannini, Caterina
    Schroeder, Mark
    Sarkaria, Jann
    Schroeder, Mark
    Puri, Raj K.
    Russell, Stephen J.
    Galanis, Evanthia
    MOLECULAR THERAPY, 2008, 16 (09) : 1556 - 1564
  • [36] Measles virus oncolytic activity in cutaneous T-cell lymphoma -: In vitro and in vivo
    K nzi, V.
    Oberholzer, P. A.
    Heinzerling, L.
    Dummer, R.
    Naim, H. Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : S28 - S28
  • [37] Designing an Enhanced EGFR-Retargeted Oncolytic Herpes Simplex Virus
    Ingusci, Selene
    Hall, Bonnie
    Marco, Marzulli
    Cohen, Justus
    Glorioso, Joseph
    MOLECULAR THERAPY, 2020, 28 (04) : 163 - 164
  • [38] Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus
    Suzuki, Takuma
    Uchida, Hiroaki
    Shibata, Tomoko
    Sasaki, Yasuhiko
    Ikeda, Hitomi
    Hamada-Uematsu, Mika
    Hamasaki, Ryota
    Okuda, Kosaku
    Yanagi, Shigeru
    Tahara, Hideaki
    MOLECULAR THERAPY-ONCOLYTICS, 2021, 22 : 265 - 276
  • [39] Expression of Immunomodulatory Neutrophil-activating Protein of Helicobacter pylori Enhances the Antitumor Activity of Oncolytic Measles Virus
    Iankov, Ianko D.
    Allen, Cory
    Federspiel, Mark J.
    Myers, Rae M.
    Peng, Kah Whye
    Ingle, James N.
    Russell, Stephen J.
    Galanis, Evanthia
    MOLECULAR THERAPY, 2012, 20 (06) : 1139 - 1147
  • [40] MiRNA Regulation of Oncolytic Measles Virus Infectivity
    Geekiyanage, Hirosha
    Galanis, Evanthia
    MOLECULAR THERAPY, 2016, 24 : S27 - S27
12345